Annenberg Center for Health Sciences at Eisenhower

Management of Metastatic Colorectal Cancer

Overview / Abstract:	Stacey Cohen, MD, explores the significance of molecular profiling and tumor markers in personalizing immunotherapy for metastatic colorectal cancer. She also delves into the evolving landscape of targeted therapies, discussing the nuances and considerations of different options to optimize patient outcomes.
Expiration	Aug 19, 2025
Discipline(s)	Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME
Format	Online
Credits / Hours	0.5
Accreditation	ACCME
Presenters / Authors / Faculty	Stacey A. Cohen, MD Fred Hutchinson Cancer Center Associate Professor, Clinical Research Division, Fred Hutch Associate Professor, Division of Hematology and Oncology, University of Washington School of Medicine Seattle, Washington
Sponsors / Supporters / Grant Providers	This activity is supported by an independent educational grant from Taiho Oncology, Inc.
Keywords / Search Terms	Annenberg Center for Health Sciences at Eisenhower Epidemiology, burden of disease, Molecular profiling and tumor markers ,Treatment planning,Targeted therapies,Subsequent therapy Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map